 Innovation Building 1 at 16 Tech Innovation District | |
| Formation | May 1, 2013 |
|---|---|
| Type | Research Institute |
| Headquarters | Indianapolis, Indiana, U.S. |
Region served | Indiana |
| Staff | 100 |
| Website | https://www.indianabiosciences.org |
The Indiana Biosciences Research Institute (IBRI) is an American nonprofit translational research organization headquartered in Indianapolis, Indiana, United States[1] within the 16 Tech Innovation District.[2] The IBRI is the nation's first industry-led collaborative life sciences research institute.[3] Its primary focus is on better understanding the pathogenesis of type 1 and type 2 diabetes to translate this knowledge into novel therapies,[4] while also expanding into other metabolic diseases that share common systems and pathways.[5]
- ^ Rudavsky, Shari (February 24, 2016). "New biosciences institute gets $100M". Indianapolis Star. Retrieved June 22, 2017.
- ^ Orr, Susan (March 16, 2022). "16 Tech Promotes Emily Krueger to Chief Executive". Indianapolis Business Journal. Retrieved August 15, 2022.
- ^ "Bioscience Research Institute Creates a 'Petri Dish' for Innovation". Crain Communications. June 30, 2016. Retrieved June 22, 2017.
- ^ "IBRI Welcomes New Leader". Inside INdiana Business. Retrieved 2022-08-16.
- ^ "How We Study Alzheimer's and Potential Treatments". Indiana University Precision Health Initiative, Healthcare Triage. Retrieved 2022-08-16.